ChemicalBook > Product Catalog >API >Blood System Drugs >Anticoagulant and Antiplatelet Drugs >Betrixaban

Betrixaban

Betrixaban Suppliers list
Company Name: Zhengzhou Anhuida Chemical Co., Ltd
Tel: +8615903659408
Email: admin@ahdchem.com
Products Intro: Product Name:Betrixaban maleate
CAS:330942-05-7
Purity:0.98 Package:10mg, 10g, 50g, 100g, 1kg, 5kg, 10kg
Company Name: Anhui Ruihan Technology Co., Ltd
Tel: +8617756083858
Email: daisy@anhuiruihan.com
Products Intro: Product Name:Betrixaban
CAS:330942-05-7
Purity:99% Package:1kg;50USD
Company Name: Beijing Cooperate Pharmaceutical Co.,Ltd
Tel: 010-60279497
Email: sales01@cooperate-pharm.com
Products Intro: Product Name:Betrixaban
CAS:330942-05-7
Purity:98%99% Package:100G;1KG;5KG;10KG;25KG;50KG;100KG
Company Name: Henan Tianfu Chemical Co.,Ltd.
Tel: +86-0371-55170693 +86-19937530512
Email: info@tianfuchem.com
Products Intro: Product Name:Betrixaban
CAS:330942-05-7
Purity:99% Package:25KG;5KG;1KG
Company Name: Hangzhou FandaChem Co.,Ltd.
Tel: 008657128800458; +8615858145714
Email: fandachem@gmail.com
Products Intro: Product Name:Betrixaban
CAS:330942-05-7
Purity:As coa Package:As request Remarks:330942-05-7

Betrixaban manufacturers

  • Betrixaban
  • Betrixaban pictures
  • $50.00 / 1kg
  • 2023-09-11
  • CAS:330942-05-7
  • Min. Order: 1kg
  • Purity: 99%
  • Supply Ability: 10000tons
  • Betrixaban
  • Betrixaban pictures
  • $0.00 / 1g
  • 2021-09-29
  • CAS:330942-05-7
  • Min. Order: 1g
  • Purity: 98%min
  • Supply Ability: 1000g
  • Betrixaban USP/EP/BP
  • Betrixaban USP/EP/BP pictures
  • $1.10 / 1g
  • 2021-08-05
  • CAS:330942-05-7
  • Min. Order: 1g
  • Purity: 99.9%
  • Supply Ability: 100 Tons min
Betrixaban Basic information
Product Name:Betrixaban
Synonyms:Betrixaban;N-(5-Chloropyridin-2-yl)-2-[[4-(N,N-dimethylcarbamimidoyl)benzoyl]amino]-5-methoxybenzamide;Betrixaban, >=98%;Betrixaban, PRT-054021;1-C-{4-[aMino(diMethylaMino)Methyl]benzene}-2-N-(5-chloropyridin-2-yl)-4-Methoxybenzene-1,2-dicarboxaMide;N-(5-Chloro-2-pyridinyl)-2-[[4-[(diMethylaMino)iMinoMethyl]benzoyl]aMino]-5-MethoxybenzaMide;PRT 054021;N-(5-chloropyridin-2-yl)-2-(4-(N,N-diMethylcarbaMiMidoyl)benzaMido)-4-MethoxybenzaMide
CAS:330942-05-7
MF:C23H22ClN5O3
MW:451.91
EINECS:682-459-2
Product Categories:API;Aromatics;Heterocycles;Inhibitors;Intermediates & Fine Chemicals;Pharmaceuticals
Mol File:330942-05-7.mol
Betrixaban Structure
Betrixaban Chemical Properties
Melting point 210-213°C
density 1.30±0.1 g/cm3(Predicted)
storage temp. 2-8°C
solubility DMSO (Slightly), Methanol (Slightly)
form Solid
pka11.00±0.70(Predicted)
color Off-White
CAS DataBase Reference330942-05-7
Safety Information
MSDS Information
Betrixaban Usage And Synthesis
UsesBetrixaban is a novel anticoagulant, an oral direct inhibitor of factor Xa (FXa) for use in the prevention of venous thromboembolism (VTE).
DefinitionChEBI: Betrixaban is a secondary carboxamide obtained by formal condensation of the carboxy group of 4-(N,N-dimethylcarbamimidoyl)benzoic acid with the amino group of 2-amino-N-(5-chloropyridin-2-yl)-5-methoxybenzamide. A synthetic anticoagulant compound that targets activated factor Xa in the coagulation cascade. It has a role as an anticoagulant and an EC 3.4.21.6 (coagulation factor Xa) inhibitor. It is a member of guanidines, a member of benzamides, a secondary carboxamide, a monochloropyridine and a monomethoxybenzene.
Biological Activitybetrixaban is a highly potent, selective, and orally efficacious inhibitor of factor xa with ic50 value of 1.5nm [1].betrixaban shows excellent anticoagulant potency in vitro. in the rabbit deep vein thrombosis model, the concentration of betrixaban required to double the rabbit prothrombin time is below 2μm. betrixaban is selective for fxa and has poor activity for thrombin, trypsin, t-pa and apc. the patch clamp herg assay shows that betrixaban has low affinity with herg suggesting it is safer than other candidate compounds. in addition, betrixaban displays a profile of good oral bioavailability and oral exposure, long half-life in animal models. it has bioavailability of 51.6% at dose of 0.5 mg/kg iv and 2.5 mg/kg po. furthermore, the phase ii study has proved betrixaban as an oral fxa inhibitor for prevention of venous thromboembolic events [1].
references[1] zhang p, huang w, wang l, bao l, jia zj, bauer sm, goldman ea, probst gd, song y, su t, fan j, wu y, li w, woolfrey j, sinha u, wong pw, edwards st, arfsten ae, clizbe la, kanter j, pandey a, park g, hutchaleelaha a, lambing jl, hollenbach sj, scarborough rm, zhu by. discovery of betrixaban (prt054021), n-(5-chloropyridin-2-yl)-2-(4-(n,n-dimethylcarbamimidoyl)benzamido)-5-methoxybenzamide, a highly potent, selective, and orally efficacious factor xa inhibitor. bioorg med chem lett. 2009 apr 15;19(8):2179-85.
Tag:Betrixaban(330942-05-7) Related Product Information
Osimertinib mesylate Gefitinib PHENRAMINE MALEATE Raltegravir N-(5-Chloro-2-pyridinyl)-2-[[4-[(dimethylamino)iminomethyl]benzoyl]amino]-5-methoxybenzamide (2Z)-2-butenedioate (1:1) Betrixaban Impurity 2 Betrixaban Impurity 1 Bendamustine Argatroban Lercanidipine Trazodone Rivaroxaban